Because of their ability to detect only one specific biomolecule, antibodies are often viewed as the best way to interact with biosensors.
A strategy to mass produce them is the Hybridoma technology (developed in 1975 by Milstein, and Köhler). Briefly, a plasma B cell is fused together with a cancer cell, in this way, the plasma B cell does not die and will keep on producing millions of specific antibodies. [1]
Antibodies work well with ELISA (Enzyme Linked Immuno Sorbent Assay) where the antibodies detect a specific antigen and they are linked next with a fluoro-enzyme(an enzyme capable of emitting light), a deep analysis on a microscope will yield the response, if everything goes well, the assay will be as bright as a field of fireflies.
Antibodies have been also used in cantilevers or membranes (MEMS) to detect by weight the presence of a given antigen. [2] The detection strategy in this case, can be optical, piezoelectric, or even by capacitance.
![]() |
Cantilever with antibodies, based on the size and weight, the cantilever can deflect downside or even upside as seen on [3] (with SCFV instead of antibodies) |
[1] Human antibodies by design, Vaughan, T. J, Osbourn, J. K, Tempest, P. R, Nature biotechnology, 16, 535-539 (1998)
[2] Cantilever transducers as a platform for chemical and biological sensors, Lavrik. N. V, Sepaniak, M. J, Datskos P. G, Review of scientific instruments, 75, 2220-2253 (2004)
[3] A label-free immunosensors array using single-chain antibody fragments, Backmann N, Zahnd C, Huber F, Bietsch A, Plückthun A, Lang H. P, Güntherodt H. J, Hegner M, Gerber C, PNAS, 102, 14587-14592 (2005)
No comments:
Post a Comment